Immunovant, Inc.IMVTNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-481.47M
↓ 151% vs avg
Percentile
P0
Near historical low
Streak
7 yr
Consecutive declineContracting
Average
$-191.88M
Historical baseline
PeriodValueYoY Change
TTM$-481.47M-10.0%
2025$-437.77M-62.2%
2024$-269.98M-29.7%
2023$-208.08M-33.5%
2022$-155.91M-44.3%
2021$-108.05M-64.6%
2020$-65.64M-687338.3%
2019$9552.00-
2018$0.00-